ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, D-, THIAMINE HYDROCHLORIDE, RIBOFLAVIN, NIACIN, PYRIDOXINE HYDROCHLORIDE, LEVOMEFOLATE MAGNESIUM, FOLIC ACID, CYANOCOBALAMIN, IRON PENTACARBONYL, POTASSIUM IODIDE, MAGNESIUM OXIDE, DOCONEXENT, and ICOSAPENT · ASCORBIC ACID 55 mg/1; CHOLECALCIFEROL 1000 [iU]/1; .ALPHA.-TOCOPHEROL ACETATE, D- 15 [iU]/1; THIAMINE HYDROCHLORIDE 1.3 mg/1; RIBOFLAVIN 1.8 mg/1; NIACIN 5 mg/1; PYRIDOXINE HYDROCHLORIDE 35 mg/1; LEVOMEFOLATE MAGNESIUM 600 ug/1; FOLIC ACID 400 ug/1; CYANOCOBALAMIN 14 ug/1; IRON PENTACARBONYL 31 mg/1; POTASSIUM IODIDE 200 ug/1; MAGNESIUM OXIDE 30 mg/1; DOCONEXENT 200 mg/1; ICOSAPENT 15 mg/1 · Capsule, Liquid Filled · Oral · CarWin Pharmaceutical Associates, LLC
NDC 15370-0250-30 · 30 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC · UNAPPROVED DRUG OTHER · View full market →
Only one company currently supplies this market — there is no backup if it stumbles. The price has held steady around $8.77 per unit over the past year. Put together: worth watching — several of the pressures that precede supply trouble are present at once.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.
The score is counting real pressure here. One of these alone is routine; it’s the combination that makes this market worth watching.
The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| CarWin Pharmaceutical Associates, LLC | ASCORBIC ACID 55 mg/1; CHOLECALCIFEROL 1000 [iU]/1; .ALPHA.-TOCOPHEROL ACETATE, D- 15 [iU]/1; THIAMINE HYDROCHLORIDE 1.3 mg/1; RIBOFLAVIN 1.8 mg/1; NIACIN 5 mg/1; PYRIDOXINE HYDROCHLORIDE 35 mg/1; LEVOMEFOLATE MAGNESIUM 600 ug/1; FOLIC ACID 400 ug/1; CYANOCOBALAMIN 14 ug/1; IRON PENTACARBONYL 31 mg/1; POTASSIUM IODIDE 200 ug/1; MAGNESIUM OXIDE 30 mg/1; DOCONEXENT 200 mg/1; ICOSAPENT 15 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| CarWin Pharmaceutical Associates, LLC | ASCORBIC ACID 15 [iU]/1; CHOLECALCIFEROL 55 mg/1; .ALPHA.-TOCOPHEROL ACETATE, D- 1000 [iU]/1; THIAMINE HYDROCHLORIDE 14 ug/1; RIBOFLAVIN 200 mg/1; NIACIN 400 ug/1; PYRIDOXINE HYDROCHLORIDE 15 mg/1; LEVOMEFOLATE MAGNESIUM 31 mg/1; FOLIC ACID 600 ug/1; CYANOCOBALAMIN 30 mg/1; IRON PENTACARBONYL 5 mg/1; POTASSIUM IODIDE 200 ug/1; MAGNESIUM OXIDE 35 mg/1; DOCONEXENT 1.8 mg/1; ICOSAPENT 1.3 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| CarWin Pharmaceutical Associates, LLC | .ALPHA.-TOCOPHEROL ACETATE, D- 15 [iU]/1; ASCORBIC ACID 55 mg/1; CHOLECALCIFEROL 1000 [iU]/1; CYANOCOBALAMIN 14 ug/1; DOCONEXENT 200 mg/1; FOLIC ACID 400 ug/1; ICOSAPENT 15 mg/1; IRON PENTACARBONYL 31 mg/1; LEVOMEFOLATE MAGNESIUM 600 ug/1; MAGNESIUM OXIDE 30 mg/1; NIACIN 5 mg/1; POTASSIUM IODIDE 200 ug/1; PYRIDOXINE HYDROCHLORIDE 35 mg/1; RIBOFLAVIN 1.8 mg/1; THIAMINE HYDROCHLORIDE 1.3 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "TriStart DHA — NDC 15370-0250-30," retrieved September 3, 2026, https://drugdashboards.com/drug/15370025030.
Free to cite with attribution — see how the data is put together.